Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Biomidwest symbols : ABT save search
Abbott Reports First-Quarter 2024 Results and Raises Midpoint of Full-Year Guidance Ranges
Published: 2024-04-17 (Crawled : 12:00) - biospace.com/
ABT | News | $108.01 0.88% 1.2M
|
Health Technology
|
| O: -0.59%
H: 0.0%
C: 0.0%
results
Tandem Diabetes Care’s t:slim X2™ Insulin Pump is the First Automated Insulin Delivery System to Integrate with Abbott’s New FreeStyle Libre® 2 Plus Sensor
Published: 2024-01-08 (Crawled : 14:00) - biospace.com/
ABT | News | $108.01 0.88% 1.2M
|
Health Technology
|
| O: 0.36%
H: 0.0%
C: 0.0%
TNDM | $33.72 6.27% 1.2M
|
Health Technology
|
| O: 0.07%
H: 3.06%
C: 1.73%
libre first freestyle sensor system diabetes plus insulin
Surmodics Announces TRANSCEND Trial 36-Month Data to be Presented at 50th Annual VEITH Symposium
Published: 2023-11-07 (Crawled : 13:00) - biospace.com/
ABT | News | $108.01 0.88% 1.2M
|
Health Technology
|
| O: -0.42%
H: 0.0%
C: 0.0%
SRDX | $26.9 5.95% 19K
|
Health Technology
|
| O: 0.69%
H: 1.71%
C: 0.95%
symposium trial transcend
Abbott Reports Second-Quarter 2023 Results; Increases Outlook For Underlying Base Business
Published: 2023-07-20 (Crawled : 13:00) - biospace.com/
ABT | News | $108.01 0.88% 1.2M
|
Health Technology
|
| O: 0.76%
H: 4.13%
C: 3.45%
business
Abbott Hosts Conference Call for Second-Quarter Earnings - June 29, 2023
Published: 2023-06-29 (Crawled : 14:00) - biospace.com/
ABT | News | $108.01 0.88% 1.2M
|
Health Technology
|
| O: -0.54%
H: 0.78%
C: 0.59%
conference
European Study Finds the Abbott CardioMEMS Sensor Results in Improved Quality of Life and 44% Reduction in Heart Failure Hospitalizations
Published: 2023-05-24 (Crawled : 16:00) - biospace.com/
ABT | News | $108.01 0.88% 1.2M
|
Health Technology
|
| O: -0.09%
H: 0.0%
C: -1.52%
life sensor heart results study
Nexus Pharmaceuticals LLC Announces Appointment of New Board Members
Published: 2023-05-11 (Crawled : 18:00) - biospace.com/
ABT | News | $108.01 0.88% 1.2M
|
Health Technology
|
| O: -0.57%
H: 0.37%
C: -0.01%
pharmaceuticals
Abbott Reports First-Quarter 2023 Results; Increases Outlook For Underlying Base Business
Published: 2023-04-19 (Crawled : 12:00) - biospace.com/
ABT | News | $108.01 0.88% 1.2M
|
Health Technology
|
| O: 4.18%
H: 3.87%
C: 3.49%
business
U.S. FDA Clears Abbott's FreeStyle Libre® 2 and FreeStyle Libre® 3 Sensors for Integration with Automated Insulin Delivery Systems
Published: 2023-03-06 (Crawled : 13:00) - biospace.com/
ABT | News | $108.01 0.88% 1.2M
|
Health Technology
|
| O: 0.06%
H: 0.09%
C: -1.68%
libre fda integration insulin
FDA Approves Abbott's Spinal Cord Stimulation for People Living with Painful Diabetic Peripheral Neuropathy
Published: 2023-01-26 (Crawled : 15:20) - biospace.com/
ABT | News | $108.01 0.88% 1.2M
|
Health Technology
|
| O: 0.23%
H: 0.33%
C: -0.16%
fda living diabetic
Kalderos Continues Momentum by Naming Lisa Bomrad its First Chief People Officer
Published: 2022-10-20 (Crawled : 12:20) - biospace.com/
ARMK | $32.27 0.06% 470K
|
Consumer Services
|
| O: 0.43%
H: 0.92%
C: -1.09%
ABT | News | $108.01 0.88% 1.2M
|
Health Technology
|
| O: -1.62%
H: 1.26%
C: -1.36%
momentum
New Study Published in The New England Journal of Medicine Demonstrates Abbott's FreeStyle Libre® 2 System Has Positive Impacts on Glucose Levels and Quality of Life
Published: 2022-10-06 (Crawled : 15:00) - biospace.com/
ABT | News | $108.01 0.88% 1.2M
|
Health Technology
|
| O: -0.5%
H: 0.34%
C: -0.4%
libre system life positive study
Study Finds 89% of Patients Treated for Persistent Atrial Fibrillation Using Abbott's Ablation Device Remain Symptom-Free for at Least 15 Months
Published: 2022-04-29 (Crawled : 14:00) - biospace.com/
ABT | News | $108.01 0.88% 1.2M
|
Health Technology
|
| O: -0.85%
H: 0.0%
C: 0.0%
device
Abbott Announces World's First Implant of Dual-Chamber Leadless Pacemaker in Pivotal Trial
Published: 2022-02-07 (Crawled : 20:00) - biospace.com/
ABT | News | $108.01 0.88% 1.2M
|
Health Technology
|
| O: 0.22%
H: 0.0%
C: 0.0%
ema implant trial
Abbott Reports Strong Fourth-Quarter 2021 Results; Issues 2022 Forecast
Published: 2022-01-26 (Crawled : 13:30) - biospace.com/
ABT | News | $108.01 0.88% 1.2M
|
Health Technology
|
| O: -3.31%
H: 2.09%
C: 0.74%
report results
Abbott Receives FDA Approval for Minimally Invasive Portico™ with FlexNav™ TAVR System to Treat Patients with Aortic Valve Disease
Published: 2021-09-20 (Crawled : 14:00) - biospace.com/
ABT | News | $108.01 0.88% 1.2M
|
Health Technology
|
| O: -1.16%
H: 0.0%
C: 0.0%
disease fda fda approval approval
Abbott Receives FDA Clearance for its Imaging Technology Using Artificial Intelligence for Vessels in the Heart
Published: 2021-08-03 (Crawled : 13:15) - biospace.com/
ABT | News | $108.01 0.88% 1.2M
|
Health Technology
|
| O: 0.38%
H: 0.96%
C: 0.61%
artificial intelligence fda clearance fda heart technology imaging clearance
Leadership Additions Announced to Support Expanding US Government and Healthcare Provider KidneyIntelX DeploymentEnabling expertise in sales, population health and value-driven care models
Published: 2021-06-07 (Crawled : 12:00) - biospace.com/
ABT | News | $108.01 0.88% 1.2M
|
Health Technology
|
| O: 0.63%
H: 0.82%
C: 0.02%
RNLX | $0.7465 62K
|
Technology Services
|
| O: 1.7%
H: 0.48%
C: -3.73%
OPK | $1.255 2.03% 690K
|
Health Technology
|
| O: 0.0%
H: 7.2%
C: 6.09%
sales
Abbott Confirms Capacity to Support Expanded Use of HeartMate 3™ Heart Pump
Published: 2021-06-03 (Crawled : 12:15) - biospace.com/
ABT | News | $108.01 0.88% 1.2M
|
Health Technology
|
| O: 0.09%
H: 2.5%
C: 2.06%
heart
Abbott Receives CE Mark for Navitor™, the Latest-Generation Transcatheter Aortic Valve Implantation (TAVI) System to Treat Aortic Stenosis
Published: 2021-05-17 (Crawled : 21:00) - biospace.com/
ABT | News | $108.01 0.88% 1.2M
|
Health Technology
|
| O: -0.26%
H: 0.3%
C: -1.07%
implant ce mark test
Gainers vs Losers
| 87% | 13% |
Top 10 Gainers
MTTR | News M | $4.595 164.08% 13M
|
AGBA | $2.61 108.8% 41M
|
Finance
CZOO | $9.32 86.77% 18M
|
EDBL | News | $6.7 78.19% 1.7M
|
MTC | $2.28 46.15% 2.6M
|
Technology Services
OPRT | News | $3.14 39.56% 7.6M
|
Finance
VNRX | $0.8 33.33% 2.9M
|
Health Technology
MLEC | $1.865 33.21% 2.4M
|
n/a
PALI | $6.37 29.21% 21M
|
Manufacturing
LOCL | $3.33 27.59% 43K
|
Your saved searches
Save your searches and get alerts when important news are released.